| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |